☆ 3.8 Article

Monitoring the safety of COVID-19 vaccination in pregnancy in the UK: A national study using the UK Obstetric Surveillance System (UKOSS), UK Teratology Information Service (UKTIS) and Vaccination in Pregnancy (VIP) safety monitoring systems

OBSTETRIC MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Obstetrics & Gynecology

Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study

M. Rottenstreich et al.

Summary: This study aimed to evaluate the impact of Covid-19 vaccination during the third trimester of pregnancy on maternal and neonatal outcomes. The results showed a vaccination rate of 40.2% in a population covered by a National Health Insurance Plan, which was not associated with adverse maternal outcomes and even decreased the risk for neonatal adverse outcomes.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Add to Collection

Review Immunology

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment

Jerome Custers et al.

Summary: This article reviews the safety and efficacy of Ad26 vector-based vaccines in clinical trials, showing good tolerability and immunogenicity in multiple studies. New developments in Ad26-based vaccines, including a COVID-19 vaccine currently in phase 3 clinical evaluation, are promising for vaccine development.

VACCINE (2021)

Add to Collection

Letter Medicine, General & Internal

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Kushalinii Hillson et al.

LANCET (2021)

Add to Collection

News Item Medicine, General & Internal

No link between COVID-19 vaccines and early pregnancy loss

[Anonymous]

MEDICAL JOURNAL OF AUSTRALIA (2021)

Add to Collection

Article Immunology

Prenatal maternal COVID-19 vaccination and pregnancy outcomes

Tamar Wainstock et al.

Summary: The study found that prenatal administration of the Pfizer-BioNTech COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. Women who received the vaccine during pregnancy were typically older, more likely to conceive following fertility treatments, and received more prenatal care, but there were no significant differences in pregnancy, delivery, or newborn complications compared to unvaccinated women.

VACCINE (2021)

Add to Collection

Article Medicine, General & Internal

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Tom T. Shimabukuro et al.

Summary: Preliminary data indicates that there are no obvious safety signals among pregnant women who received mRNA Covid-19 vaccines, but more data is needed for further confirmation. Adverse reactions such as injection-site pain were reported more frequently in pregnant women, but most pregnancies resulted in live births with some cases of preterm birth and small size for gestational age.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS)

Nicola Vousden et al.

Summary: The study identified factors that increase the risk of symptomatic and asymptomatic SARS-CoV-2 infection in pregnancy. Clinicians can be reassured that the majority of women do not experience severe complications of SARS-CoV-2 in pregnancy. Cesarean birth rates and neonatal unit admission rates were increased for pregnant women with symptomatic and asymptomatic SARS-CoV-2. The risks of stillbirth or neonatal death were not significantly increased.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women

Inbal Goldshtein et al.

Summary: The retrospective cohort study found that BNT162b2 mRNA vaccination in pregnant women was associated with a significantly reduced risk of SARS-CoV-2 infection compared to no vaccination. However, interpretation of the study findings is limited by the observational design.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Medicine, General & Internal

Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy

Elyse O. Kharbanda et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Acoustics

Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine

S. Bookstein Peretz et al.

Summary: This observational study compared the immunogenicity and reactogenicity of the Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine between pregnant and non-pregnant women. The study found that pregnant women experienced similar rates of adverse effects following vaccination as non-pregnant women, with lower levels of SARS-CoV-2 IgG. The vaccine was effective in generating a humoral immune response in pregnant women, with no safety concerns identified.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout

Alisa Kachikis et al.

Summary: This cohort study compared short-term reactions following COVID-19 vaccination between pregnant and lactating individuals and those who are not pregnant or lactating but planning pregnancy.

JAMA NETWORK OPEN (2021)

Add to Collection

Letter Obstetrics & Gynecology

COVID-19 vaccination in pregnancy: early experience from a single institution

Megan E. Trostle et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Add to Collection

Article Obstetrics & Gynecology

Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy

Regan N. Theiler et al.

Summary: In this study, pregnant women who received COVID-19 vaccination were less likely to contract COVID-19 compared to those who did not receive the vaccine, and vaccination during pregnancy did not lead to increased risks of pregnancy or delivery complications. Factors such as older age, higher education level, non-smoking status, use of infertility treatment during current pregnancy, and lower gravidity were associated with a higher likelihood of vaccination.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Add to Collection

Letter Medicine, General & Internal

Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage

Maria C. Magnus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Marian Knight et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Include pregnant women in research-particularly covid-19 research

Marian Knight et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Medicine, General & Internal

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

John Allotey et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Reproductive Biology

Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study

J. L. Richardson et al.

REPRODUCTIVE TOXICOLOGY (2019)

Add to Collection

© Peeref 2019-2024. All rights reserved.